Literature DB >> 14989406

The stress cascade and schizophrenia: etiology and onset.

Cheryl Corcoran1, Elaine Walker, Rebecca Huot, Vijay Mittal, Kevin Tessner, Lisa Kestler, Dolores Malaspina.   

Abstract

Psychosocial stress is included in most etiologic models of schizophrenia, frequently as a precipitating factor for psychosis in vulnerable individuals. Nonetheless, the stress-diathesis model has not been tested prospectively in prodromal patients as a predictor of psychosis. The biological effects of stress are mediated by the hypothalamic-pituitary-adrenal (HPA) axis, which governs the release of steroids, including cortisol. The past few decades have witnessed an increased understanding of the neural effects of stress and cortisol, including both normal and abnormal diatheses. As few biological markers have been evaluated as risk factors for psychosis in prodromal patients, the HPA axis and its interaction with intervening life events are apt candidates for study. In this article, we review the HPA axis and its neural effects, present a model for how stress might precipitate psychosis in vulnerable individuals, review the empirical evidence of a link between stress and schizophrenia symptoms, and propose a research design and appropriate statistical models to test the stress-diathesis model for psychosis onset in prodromal patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14989406     DOI: 10.1093/oxfordjournals.schbul.a007038

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  115 in total

1.  Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.

Authors:  Clemente Garcia-Rizo; Emilio Fernandez-Egea; Cristina Oliveira; Azucena Justicia; Miguel Bernardo; Brian Kirkpatrick
Journal:  Psychiatry Res       Date:  2012-03-08       Impact factor: 3.222

2.  Culture, stress and recovery from schizophrenia: lessons from the field for global mental health.

Authors:  Neely Laurenzo Myers
Journal:  Cult Med Psychiatry       Date:  2010-09

Review 3.  Developmental pathology, dopamine, stress and schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Int J Dev Neurosci       Date:  2010-08-19       Impact factor: 2.457

4.  Neurophysiological evidence for emotion regulation impairment in schizophrenia: The role of visual attention and cognitive effort.

Authors:  Lisa A Bartolomeo; Adam J Culbreth; Kathryn L Ossenfort; Gregory P Strauss
Journal:  J Abnorm Psychol       Date:  2020-06-11

5.  Disseminating evidence-based practices for adults with PTSD and severe mental illness in public-sector mental health agencies.

Authors:  B Christopher Frueh; Anouk L Grubaugh; Karen J Cusack; Jon D Elhai
Journal:  Behav Modif       Date:  2008-08-22

6.  Effects of early trauma on psychosis development in clinical high-risk individuals and stability of trauma assessment across studies: a review.

Authors:  Samantha L Redman; Cheryl M Corcoran; David Kimhy; Dolores Malaspina
Journal:  Arch Psychol (Chic)       Date:  2017-12-18

7.  Abnormal stress responsivity in a rodent developmental disruption model of schizophrenia.

Authors:  Eric C Zimmerman; Mark Bellaire; Samuel G Ewing; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-05-08       Impact factor: 7.853

8.  Ambulatory and challenge-associated heart rate variability measures predict cardiac responses to real-world acute emotional stress.

Authors:  Gülce N Dikecligil; Lilianne R Mujica-Parodi
Journal:  Biol Psychiatry       Date:  2010-03-17       Impact factor: 13.382

9.  Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis.

Authors:  Judy L Thompson; Meredith Kelly; David Kimhy; Jill M Harkavy-Friedman; Shamir Khan; Julie W Messinger; Scott Schobel; Ray Goetz; Dolores Malaspina; Cheryl Corcoran
Journal:  Schizophr Res       Date:  2009-01-25       Impact factor: 4.939

10.  Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.

Authors:  Yijuan Du; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-04-23       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.